As of January 2014, the EMA lifted the restriction on providing fee reductions to large companies developing new orphan drugs and the Early Access to Medicines Scheme was introduced. Key implementation of this will be a factor into further commercialisation and developments.
Based on this information SMi Group is proud to announce it will be hosting the 3rd annual conference on Orphan Drugs and Rare Diseases and bringing together leading experts and companies such as Novabiotics, Pfizer, AstraZeneca, GMP Orphan SAS, Genethon and M&C Saatchi and many more to discuss the latest developments in the market.
Medical device and medical device data system (MDDS) companies seeking funding are invited to apply to present at the Southeastern Medical Device Association’s (SEMDA) 8th annual conference to be held May 7-8, 2014 at the Waverly Hotel and Convention Center in Atlanta, GA. Application deadline is March 10, 2014.
Applications are now available at www.semda.net/conference and at the following link: http://www.semda.net/pages/conference/presenting-companies.php. There is no charge to apply. For companies selected (and that choose to present), the cost is just $795, which includes two conference admissions. Each accepted company will be provided a mentoring team of industry experts that includes an investor and a CEO, plus experts in legal, commercialization and finance.
“SEMDA is raising the bar in 2014 and seeking early growth and growth equity phase companies headquartered in the Southeast and mid-Atlantic that are seeking investment,” stated Bob Crutchfield, President Of SEMDA and General Partner at Harbert Venture Partners. “As an institutional investor, former industry executive, and this year’s SEMDA President, we are extending the pull of the investment community from a National footprint to include strategics, venture capitalists and angel investors. The 2014 SEMDA Conference will be the site where invention and investment meet.”
SEMDA again will recognize the “Presenting Company Spotlight Award.” The winner will be chosen by an independent panel of judges and the audience and will be announced at the end of the conference.
“The companies that we have met through the SEMDA conference have been invaluable to Brookhaven in building our portfolio,” said John Feltman, Director of Brookwood Investments. “In addition to our recent investment in CreatiVasc Medical, we are in active discussions with several other companies that we met through SEMDA relationships. SEMDA has become an extremely valuable network for both investors and medical device companies in the Southeast.”
Companies selected will present to seed investors, angel investors, venture capitalists, private equity firms and corporations focused on medical device investment and new technology acquisition. The 2014 conference will also feature high value speakers including Steve Ubl, President of AdvaMed, discussing national medical device legislation and policy updates, and Jeffry Shuren, MD of the FDA CDRH, who will be providing the latest FDA updates. Informative programs focused on the conference theme, “Thriving During Healthcare Reform,” will be part of the two day event, which includes 1:1 partnering, presentation of the SpotLight Awards and opportunities for attendees to make meaningful industry connections. Returning again will be the highly regarded Gala on the evening of May 7th.
Recognized as the premier gathering for the Southeast medical device industry, SEMDA’s conference offers opportunities for medical device companies to grow their business and build effective networks by bringing together professionals nationally and from throughout the Southeast to connect, learn and grow.
Early bird registration is now available. To register or receive more information about the conference, sponsorship opportunities and presenting company applications, visit www.semda.net or contact email@example.com.
The Southeastern Medical Device Association (SEMDA) is a non-profit trade association that supports and promotes medical device companies in the Southeast. Created in 2004, the association provides a unique resource and networking opportunity for medical device companies, inventors, physicians, and investors interested in accelerating the growth of the medical device industry in the Southeast. Through quarterly and members-only meetings, as well as its highly regarded annual Conference, SEMDA meets the needs of members of the medical device community. Learn more at www.semda.net.
Media Contact: Joanne Martin Sanders
SOURCE Southeastern Medical Device Association (SEMDA)
The Qatar biomedical research Institute (QBRI) can host a conference on systems ‘Biology for polygenic disorder and Cancer: Towards exactitude Medicine’ on twenty six and twenty seven of this month.
Held at Qatar National Convention Centre, the conference aims to pile up scientists from round the globe to share their experiences with students and different interested parties in Qatar.
During the gap ceremony, Dr physiologist Thorens from Centre for Integrative genetics, Department of physiology, University of Lausanne, Swiss Confederation, can deliver the keynote address on ‘Mouse genetic, genomic, and physiology to uncover novel pathways dominant isle operate. Dr Thomas Zachariah, government vice-president, Qatar Foundation analysis and Development, Dr Abdelali Haoudi, decision maker, QBRI and Dr Philippe Froguel, senior scientific director, QBRI will address the gathering throughout the gap session.
The conference can cowl exactitude medication, Associate in Nursing innovative approach to medication which includes totally different analysis and patient knowledge to raised perceive individual unwellness patterns, like polygenic disorder and cancer. throughout the two-day conference, world’s leading scientists can reply to QBRI concepts and to contribute to formulating a path forward towards the creation of a significant genomic medication and system biology analysis for polygenic disorder and women’s cancer world network.
The major goals of the event ar to shed light-weight on new developments in genomic medication for the understanding and innovative treatment of polygenic disorder and cancer, to debate opportunities for regional and world networks for sort a pair of polygenic disorder and women’s cancer likewise on produce a foremost strategic analysis programme for system biology approaches towards individualised medication of polygenic disorder and women’s cancer.
On the second day, there’ll be 2 workshops handling some major challenges in polygenic disorder and cancer.
The first workshop can discuss System Biology in Diabetes: Challenges and Opportunities and therefore the different one can discuss System Biology in Women’s Cancer: Challenges and Opportunities. throughout the workshops, Dr Philippe Froguel of QBRI can gift a paper on the subject of the road towards individualised medication in sort a pair of polygenic disorder and Dr Jeremie Arash from QBRI can discuss the subject of the road towards individualised medication in female internal reproductive organ cancer.
Source: Gulf Times – News Link
The ‘International Conference on Radiation Protection in Medicine’ will be held from 30 May to 2 June 2014 in Varna, Bulgaria.
The purpose of the conference is to bring together a range of professionals involved in radiation protection to discuss the critical aspects of radiation protection in medicine.
The event revolves around the theme ‘Facing increasing challenges’ in order to assess how much difference has been made in the last four years in medical practice.
It will gather a spectrum of medical specialists including imaging and therapy practitioners, engineers, radiographers, regulators, manufacturers and patient organisations.
For further information, please visit:
Data Source Provider: Roentgen Foundation
Document Reference: Based on an event announcement
Subject Index: Healthcare delivery/services; Medicine, Health
IRIDEX today announced a number of key international conferences and workshops that will feature its proprietary MicroPulse Laser Therapy for the treatment of diabetes and glaucoma related disorders.
The upcoming European Society of Retina Specialists (EURETINA) conference in Hamburg, Germany will feature an official Instructional Course on the use of IRIDEX’ MicroPulse Therapy for retinal disorders such as those caused by complications of diabetes. EURETINA is Europe’s largest society of retina specialists. Continue reading Global Medical Conferences to Feature IRIDEX Proprietary MicroPulse™ Laser Therapy
OMICS Group invites all the participants across the globe to attend the “4th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems” slated on March 24-26, 2014 at Hilton San Antonio Airport, USA.Recent development in micro, nano-drug delivery systems, novel pre-formulation, formulation approaches and strategies like diffusion controlled delivery have reoriented the focus of almost all the Pharmaceutical and Biopharmaceutical R&D’s towards Novel Drug Delivery Systems (NDDS), diverting a major section of research to focus on formulating a variety of poorly soluble and highly unstable substances, reporting it to be the significant arena in pharmaceutical research.
In past three conferences, we focused on exploring the novel research in the field of Pharmaceutics and NDDS, this year we invite you to witness and share your experiences with the world leaders from Pharmaceutical and Biopharmaceutical Research rendering their expertise in Pre-formulation, Formulation, and Physiological approaches associated with pharmaceutical moieties.
News source and details at :Pharmaceutics & Novel Drug Delivery Systems International Conference 2014 | San Antonio | 169th OMICS Group Meeting.
With a growing epidemic of non-communicable diseases, cancers, and lifestyle diseases among women in the Middle East, periodic health assessments and screenings are important tools to identify and minimise potential health risks. Experts highlight that these assessments are especially important for women above the age of 40 because at this age, chronic diseases and cancers are most prevalent.
Dr. Fayza Naser, Specialist Physician, Family Medicine, Sheikh Khalifa Medical City, Abu Dhabi, UAE, will be presenting a talk on �Healthcare for women over 40′ as one of the important topics featured at the Family Medicine Conference at this year’s Abu Dhabi Medical Congress and Exhibition, which will be held from 27th-29th October 2013 at the Abu Dhabi National Exhibition Centre (ADNEC).
Dr. Naser highlights that as adults, biological factors related to gender can influence health, well-being outcomes, and treatment choices. Women’s health is about all the issues that affect women, encompassing all functions related to their mental and physical wellness throughout their whole lives.
Discover the latest Earth and space science news at the 46th annual AGU Fall Meeting this December, when about 20,000 scientists from around the globe are expected to assemble for the largest worldwide conference in the geophysical sciences. This year, the meeting runs from Monday through Friday, Dec. 9-13, at the Moscone Center, 747 Howard St., San Francisco, Calif. Continue reading American Geophysical Union’s 46th annual Fall Meeting Fall Meeting: Press registration open
On 16 May, 2013 – the British Embassy’s Science and Innovation Officer together with the Polish Ministry of Science and the University of Gdansk organized an international conference on Biomedical research – legal, ethical and societal aspects. Continue reading British Embassy in Poland co-organises a biomedical research conference